10-K/A

AMENDMENT NO.2 TO FORM 10-K

Company: Cue Biopharma, Inc.
Filed: July 9, 2019
Period of Report: December 31, 2018
Accession Number: 0001193125-19-191276

View Document ↗ View on SEC.gov ↗